These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27598247)

  • 1. Claudin-2 Expression Levels in Ulcerative Colitis: Development and Validation of an In-Situ Hybridisation Assay for Therapeutic Studies.
    Randall K; Henderson N; Reens J; Eckersley S; Nyström AC; South MC; Balendran CA; Böttcher G; Hughes G; Price SA
    PLoS One; 2016; 11(9):e0162076. PubMed ID: 27598247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of toll-like receptor 3 agonist poly I:C on intestinal mucosa and epithelial barrier function in mouse models of acute colitis.
    Zhao HW; Yue YH; Han H; Chen XL; Lu YG; Zheng JM; Hou HT; Lang XM; He LL; Hu QL; Dun ZQ
    World J Gastroenterol; 2017 Feb; 23(6):999-1009. PubMed ID: 28246473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiRNA-182-5p aggravates experimental ulcerative colitis via sponging Claudin-2.
    Tang S; Guo W; Kang L; Liang J
    J Mol Histol; 2021 Dec; 52(6):1215-1224. PubMed ID: 34623552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of Intestinal Mucosal Healing and Tight Junction Protein Expression in Ulcerative Colitis Patients.
    Tan Y; Guan Y; Sun Y; Zheng C
    Am J Med Sci; 2019 Mar; 357(3):195-204. PubMed ID: 30638599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D regulates the tight-junction protein expression in active ulcerative colitis.
    Stio M; Retico L; Annese V; Bonanomi AG
    Scand J Gastroenterol; 2016 Oct; 51(10):1193-9. PubMed ID: 27207502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease.
    Zeissig S; Bürgel N; Günzel D; Richter J; Mankertz J; Wahnschaffe U; Kroesen AJ; Zeitz M; Fromm M; Schulzke JD
    Gut; 2007 Jan; 56(1):61-72. PubMed ID: 16822808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of AVX-470, an Oral, Locally Acting Anti-Tumour Necrosis Factor Antibody, on Tissue Biomarkers in Patients with Active Ulcerative Colitis.
    Hartman DS; Tracey DE; Lemos BR; Erlich EC; Burton RE; Keane DM; Patel R; Kim S; Bhol KC; Harris MS; Fox BS
    J Crohns Colitis; 2016 Jun; 10(6):641-9. PubMed ID: 26802087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT6 deficiency ameliorates severity of oxazolone colitis by decreasing expression of claudin-2 and Th2-inducing cytokines.
    Rosen MJ; Chaturvedi R; Washington MK; Kuhnhein LA; Moore PD; Coggeshall SS; McDonough EM; Weitkamp JH; Singh AB; Coburn LA; Williams CS; Yan F; Van Kaer L; Peebles RS; Wilson KT
    J Immunol; 2013 Feb; 190(4):1849-58. PubMed ID: 23303670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the expression of claudins in active ulcerative colitis.
    Oshima T; Miwa H; Joh T
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S146-50. PubMed ID: 19120888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in the immunohistochemical expression of Das-1 and CG-3 in colonic mucosal biopsy specimens helps distinguish ulcerative colitis from Crohn disease and from other forms of colitis.
    Yantiss RK; Das KM; Farraye FA; Odze RD
    Am J Surg Pathol; 2008 Jun; 32(6):844-50. PubMed ID: 18408596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salmonella infection upregulates the leaky protein claudin-2 in intestinal epithelial cells.
    Zhang YG; Wu S; Xia Y; Sun J
    PLoS One; 2013; 8(3):e58606. PubMed ID: 23505542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticotropin releasing hormone in colonic mucosa in patients with ulcerative colitis.
    Kawahito Y; Sano H; Mukai S; Asai K; Kimura S; Yamamura Y; Kato H; Chrousos GP; Wilder RL; Kondo M
    Gut; 1995 Oct; 37(4):544-51. PubMed ID: 7489943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rodent IRR-219 (IgGFcgammaBP) and rTFF3, expressed mainly in the intestinal mucosa, depleted during dextran sulfate sodium-induced colitis.
    Feng ZM; Fang DC; Chen WS; Wang RQ
    Dig Dis Sci; 2007 Sep; 52(9):2104-12. PubMed ID: 17436098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease.
    Tang R; Yang G; Zhang S; Wu C; Chen M
    Inflamm Bowel Dis; 2014 Nov; 20(11):1950-61. PubMed ID: 25208103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased membrane permeation and blood concentration of 6-carboxyfluorescein associated with dysfunction of paracellular route barrier in the small intestine of ulcerative colitis model rats.
    Kumagai M; Ishii M; Morimoto K; Tomita M
    Biopharm Drug Dispos; 2020 Mar; 41(3):91-100. PubMed ID: 32043274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution.
    Heller F; Florian P; Bojarski C; Richter J; Christ M; Hillenbrand B; Mankertz J; Gitter AH; Bürgel N; Fromm M; Zeitz M; Fuss I; Strober W; Schulzke JD
    Gastroenterology; 2005 Aug; 129(2):550-64. PubMed ID: 16083712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of Vitamin D Receptor Leads to Hyperfunction of Claudin-2 in Intestinal Inflammatory Responses.
    Zhang YG; Lu R; Xia Y; Zhou D; Petrof E; Claud EC; Sun J
    Inflamm Bowel Dis; 2019 Jan; 25(1):97-110. PubMed ID: 30289450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of RANTES expression in Crohn's disease and ulcerative colitis: an aid in the differential diagnosis?
    Ansari N; Abdulla J; Zayyani N; Brahmi U; Taha S; Satir AA
    J Clin Pathol; 2006 Oct; 59(10):1066-72. PubMed ID: 16565224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Fibrosis in Acute and Longstanding Ulcerative Colitis.
    de Bruyn JR; Meijer SL; Wildenberg ME; Bemelman WA; van den Brink GR; D'Haens GR
    J Crohns Colitis; 2015 Nov; 9(11):966-72. PubMed ID: 26245217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression of group II phospholipase A2 in intestine in ulcerative colitis.
    Haapamäki MM; Grönroos JM; Nurmi H; Alanen K; Kallajoki M; Nevalainen TJ
    Gut; 1997 Jan; 40(1):95-101. PubMed ID: 9155583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.